share_log

Novavax | 4: Statement of changes in beneficial ownership of securities-Director YOUNG JAMES F

Novavax | 4: Statement of changes in beneficial ownership of securities-Director YOUNG JAMES F

诺瓦瓦克斯医药 | 4:持股变动声明-董事 YOUNG JAMES F
美股sec公告 ·  06/14 16:06
Moomoo AI 已提取核心信息
James F. Young, associated with Novavax Inc [NVAX], completed a transaction on 06/12/2024 involving the acquisition of 6,670 shares of common stock at no cost. This transaction was categorized as an exercise or conversion of derivative security, directly increasing Young's holdings to a total of 76,760 shares of Novavax common stock.
James F. Young, associated with Novavax Inc [NVAX], completed a transaction on 06/12/2024 involving the acquisition of 6,670 shares of common stock at no cost. This transaction was categorized as an exercise or conversion of derivative security, directly increasing Young's holdings to a total of 76,760 shares of Novavax common stock.
诺瓦瓦克斯医药[NVAX]相关人员詹姆斯·F·杨于2024年06月12日完成了一笔交易,免费获得了6,670股普通股。此次交易被归类为衍生证券行权或转换,直接增加了杨先生持有的诺瓦瓦克斯医药普通股总数至76,760股。
诺瓦瓦克斯医药[NVAX]相关人员詹姆斯·F·杨于2024年06月12日完成了一笔交易,免费获得了6,670股普通股。此次交易被归类为衍生证券行权或转换,直接增加了杨先生持有的诺瓦瓦克斯医药普通股总数至76,760股。
声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息